// App-Quantinova.ai

3025 : Association of Cth Genetic Variant with Veno-Occlusive Disease in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation.

Researchers

Presenter

  • Chakradhara Rao Uppungunduri

Principal Investigators

  • Anuj Kumar Tyagi

  • Mohamed Aziz Rezgui

  • Fabienne Gumy-Pause

  • Michel Duval

  • Henrique Bittencourt

  • Maja Krajinovic

  • Marc Ansari

Medical Centers

  • Department of Pediatrics, Onco-Haematology unit, Geneva University Hospital, Faculty of Medicine, Geneva, Switzerland

  • CHU Sainte-Justine Research Center, Charles-Bruneau Cancer Center, Montreal, Canada

Locations

  • Canada

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Glutathione

  • Glutathione S-Transferase Alpha 1

Drug/Treatment

  • Ursodeoxycholic acid

  • Defibrotide

  • glutathione

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved